Stergios J. Moschos
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Cancer Genomics and Diagnostics
Most-Cited Works
- → Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib(2012)2,141 cited
- → Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial(2015)1,554 cited
- → Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain(2018)1,298 cited
- → Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial(2017)763 cited
- → Leptin and reproduction: a review(2002)555 cited
- → The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications(2002)370 cited
- → Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma(2013)363 cited
- → Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays(2009)333 cited
- → Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis(2016)293 cited
- → Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-α System in Humans1(1997)273 cited